INS and type 2 diabetes mellitus: BCAA levels demonstrate striking power as predictive biomarkers of T2D (65, 66) and BCAA catabolism is intricately entwined with metabolic homeostasis (67), insulin secretion, adipocyte differentiation (68, 69), energy homeostasis (70), inflammation (71, 72) and appetite (73).